Cargando…
CD109 Promotes Drug Resistance in A2780 Ovarian Cancer Cells by Regulating the STAT3-NOTCH1 Signaling Axis
Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy owing to relapse caused by resistance to chemotherapy. We previously reported that cluster of differentiation 109 (CD109) expression is positively correlated with poor prognosis and chemoresistance in patients with EOC. To f...
Autores principales: | Kim, Jun Se, Shin, Min Joo, Lee, Seo Yul, Kim, Dae Kyoung, Choi, Kyung-Un, Suh, Dong-Soo, Kim, Dayea, Kim, Jae Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299649/ https://www.ncbi.nlm.nih.gov/pubmed/37373457 http://dx.doi.org/10.3390/ijms241210306 |
Ejemplares similares
-
Prognostic Significance of CD109 Expression in Patients with Ovarian Epithelial Cancer
por: Kim, So Young, et al.
Publicado: (2019) -
CD166 promotes the cancer stem-like properties of primary epithelial ovarian cancer cells
por: Kim, Dae Kyoung, et al.
Publicado: (2020) -
TRIB2 Stimulates Cancer Stem-Like Properties through Activating the AKT-GSK3β-β-Catenin Signaling Axis
por: Kim, Dae Kyoung, et al.
Publicado: (2021) -
Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells
por: Yang, Wookyeom, et al.
Publicado: (2021) -
Cytotoxic Effects of Strawberry, Korean Raspberry, and Mulberry Extracts on Human Ovarian Cancer A2780 Cells
por: Lee, Dahae, et al.
Publicado: (2016)